387 related articles for article (PubMed ID: 26662951)
1. Patient satisfaction after sclerotherapy of venous malformations in children.
Nakahata K; Uehara S; Zenitani M; Nakamura M; Osuga K; Okuyama H
Pediatr Int; 2016 Aug; 58(8):721-5. PubMed ID: 26662951
[TBL] [Abstract][Full Text] [Related]
2. Intralesional sclerotherapy for subcutaneous venous malformations in children.
Uehara S; Osuga K; Yoneda A; Oue T; Yamanaka H; Fukuzawa M
Pediatr Surg Int; 2009 Aug; 25(8):709-13. PubMed ID: 19582463
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous sclerotherapy of peripheral venous malformations in pediatric patients.
Gulsen F; Cantasdemir M; Solak S; Gulsen G; Ozluk E; Numan F
Pediatr Surg Int; 2011 Dec; 27(12):1283-7. PubMed ID: 21818522
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous sclerotherapy for spongiform venous malformations - analysis of patient-evaluated outcome and satisfaction.
Clemens RK; Baumann F; Husmann M; Meier TO; Thalhammer C; MacCallum G; Amann-Vesti BR; Alomari AI
Vasa; 2017 Oct; 46(6):477-483. PubMed ID: 28841126
[TBL] [Abstract][Full Text] [Related]
5. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
[TBL] [Abstract][Full Text] [Related]
6. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of Duplex-guided polidocanol foam sclerotherapy for venous malformations.
Ali H; Saleh M; Mohammed W
Int Angiol; 2017 Jun; 36(3):228-236. PubMed ID: 27362577
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-guided polidocanol foam sclerotherapy for treating venous malformations.
Kumar S; Bhavana K; Kumar S; Kumar P
J Clin Ultrasound; 2018 Jan; 46(1):23-31. PubMed ID: 29080330
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of polidocanol sclerotherapy in alleviating symptoms in patients with venous malformations.
Guzelbey T; Cingoz M; Erdim C; Mutlu IN; Kılıckesmez O
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101698. PubMed ID: 37890587
[TBL] [Abstract][Full Text] [Related]
10. Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications.
Ierardi AM; Mangini M; Vaghi M; Cazzulani A; Carrafiello G; Mattassi R
Vasc Endovascular Surg; 2010 May; 44(4):282-8. PubMed ID: 20403950
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
J Vasc Surg; 2008 Mar; 47(3):578-84. PubMed ID: 18295109
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
Spence J; Krings T; TerBrugge KG; Agid R
Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
[TBL] [Abstract][Full Text] [Related]
13. Absolute ethanol sclerotherapy for venous malformations in the face and neck.
Su L; Fan X; Zheng L; Zheng J
J Oral Maxillofac Surg; 2010 Jul; 68(7):1622-7. PubMed ID: 19962811
[TBL] [Abstract][Full Text] [Related]
14. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
Li L; Feng J; Zeng XQ; Li YH
J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
[TBL] [Abstract][Full Text] [Related]
15. Venous Malformations Sclerotherapy: Outcomes, Patient Satisfaction and Predictors of Treatment Success.
Khaitovich B; Kalderon E; Komisar O; Eifer M; Raskin D; Rimon U
Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1695-1701. PubMed ID: 31538233
[TBL] [Abstract][Full Text] [Related]
16. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study.
Andreisek G; Nanz D; Weishaupt D; Pfammatter T
J Vasc Interv Radiol; 2009 Jul; 20(7):879-87. PubMed ID: 19481473
[TBL] [Abstract][Full Text] [Related]
17. Long-term patient satisfaction after percutaneous treatment of peripheral vascular malformations.
van der Linden E; Pattynama PM; Heeres BC; de Jong SC; Hop WC; Kroft LJ
Radiology; 2009 Jun; 251(3):926-32. PubMed ID: 19336668
[TBL] [Abstract][Full Text] [Related]
18. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin.
Liu Y; Liu D; Wang Y; Zhang W; Zhao F
J Oral Maxillofac Surg; 2009 Jan; 67(1):98-104. PubMed ID: 19070754
[TBL] [Abstract][Full Text] [Related]
19. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
Kishi K; Morita N; Terada T; Sato M
Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
[TBL] [Abstract][Full Text] [Related]
20. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
